2023
DOI: 10.3390/antibiotics12050924
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity and Antibiofilm Activity of Silver-Polypropylene Nanocomposites

Denise Bellisario,
Loredana Santo,
Fabrizio Quadrini
et al.

Abstract: The development of biocompatible nanomaterials that interface with human skin and tissue is critical for advancing prosthetics and other therapeutic medical needs. In this perspective, the development of nanoparticles with cytotoxicity and antibiofilm properties and biocompatibility characteristics are important. Metallic silver (Ag) exhibits good biocompatibility, but it is often challenging to integrate it into a nanocomposite without compromising its antibiofilm properties for optimal applications. In this … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 43 publications
0
1
0
Order By: Relevance
“…Toxicity doesn't just pertain to bacterial cells but also to eukaryotic cells, as nanoparticles may exhibit some degree of cytotoxicity. [26,27] The cytotoxicity assay showed moderate toxicity in the AgNPs impregnated bone scaffold we developed, similar with previous cited publications. Another issue with the use of silver is its discoloration, which can stain teeth or skin when applied directly to these tissues [28].…”
Section: Discussionsupporting
confidence: 86%
“…Toxicity doesn't just pertain to bacterial cells but also to eukaryotic cells, as nanoparticles may exhibit some degree of cytotoxicity. [26,27] The cytotoxicity assay showed moderate toxicity in the AgNPs impregnated bone scaffold we developed, similar with previous cited publications. Another issue with the use of silver is its discoloration, which can stain teeth or skin when applied directly to these tissues [28].…”
Section: Discussionsupporting
confidence: 86%
“…However, bacteria develop Pharmaceutics 2023, 15, 1871. https://doi.org/10.3390/pharmaceutics15071871 https://www.mdpi.com/journal/pharmaceutics resistance to antibiotics fast, and so to control the pathogenic bacteria population, there is a need to develop new types of antibacterial agents that bacteria cannot develop resistance to soon [1,2]. Metal or metal oxide nanoparticles [3,4], carbon nanotubes [5], short polypeptides [6], and bacterial topoisomerase inhibitors [7] are considered as a base for such agents that are alternatives to antibiotics. In recent years, porcine myeloid antimicrobial peptides have been mentioned with increasing frequency due to their strong antimicrobial activity [8].…”
Section: Introductionmentioning
confidence: 99%